Brian Mann

A group of state attorneys general negotiating with members of the Sackler family says they expect Purdue Pharma to file for bankruptcy "imminently," according to an email obtained by NPR.

Purdue Pharma, Johnson & Johnson and other drug firms accused of fueling the nation's opioid epidemic are in talks trying to reach legal settlements that could reach tens of billions of dollars.

Purdue Pharma, Johnson & Johnson and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic.

Purdue Pharma, the maker of OxyContin, faces billions of dollars in potential liability for its role in the nation's opioid crisis.

A court order that Johnson and Johnson pay Oklahoma $572 million for its role in the opioid crisis is good news for the other state and local governments bringing cases against the opioid industry.

In a landmark ruling, Judge Thad Balkman ruled in favor of Oklahoma in its lawsuit to hold the drugmaker accountable for the costs of opioid addiction in the state.

The first major opioid trial in the country wraps up Monday. An Oklahoma judge will rule in a $17 billion civil suit filed by the state against Johnson & Johnson.

Documents released as part of the biggest opioid litigation case reveal more internal emails from drug industry executives voicing indifference to addiction risks and the over-use of opioids.

As addiction has soared, drugmakers, distributors and pharmacies profited off opioids. Newly released data details who made the pills, where they were sold, and which communities were hit hardest.

The deal to resolve all U.S. federal investigations and claims is the biggest drug industry settlement so far stemming from the nation's deadly opioid epidemic.

It's the biggest settlement yet in the nation's opioid crisis: the company that marketed Suboxone Film, an opioid treatment drug, will pay $1.4 billion to settle claims of fraudulent marketing.

Drug companies are paying hundreds of millions of dollars to end lawsuits tied to the opioid epidemic. As payouts grow, government leaders are fighting over where the money should go.

Feuding state parties have reached a compromise over how to spend the $85 million the state won in a settlement with a pharmaceutical company which was being sued over its role in the opioid crisis.

New York is set to enact plans to battle climate change. It would go further than some other states in cutting carbon emissions from electricity, buildings and transportation.

During each episode of their intimate podcast, Will and Bella Doolittle chronicle aspects of her illness and the inner workings of their two-decade-long marriage.

Alzheimer's disease puts incredible strain on relationships. One couple in New York is talking publicly about how the disease is changing their marriage.

Attorneys who represent hundreds of local governments have a new proposal for how to deal with the opioid crisis. They unveiled the framework for nationwide settlement in federal court on Friday.

If finalized, such a deal could funnel tens of billions of dollars to American communities struggling with the addiction crisis, while restoring stability to one of the country's biggest industries.

Many of the industry's biggest companies, such as Johnson & Johnson, are tangled up in litigation. The latest filing was by Insys Therapeutics after a $225-million settlement agreement.

The pharmaceutical industry is facing hundreds of lawsuits around the country from state and local officials, who want the industry to help pay to tackle the opioid epidemic.